Persistent Human Papillomavirus Infection.

HPV cancer epithelium extrachromosomal replication immune evasion latency papillomavirus persistence tethering

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
20 02 2021
Historique:
received: 16 01 2021
revised: 16 02 2021
accepted: 17 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 13 8 2021
Statut: epublish

Résumé

Persistent infection with oncogenic human papillomavirus (HPV) types is responsible for ~5% of human cancers. The HPV infectious cycle can sustain long-term infection in stratified epithelia because viral DNA is maintained as low copy number extrachromosomal plasmids in the dividing basal cells of a lesion, while progeny viral genomes are amplified to large numbers in differentiated superficial cells. The viral E1 and E2 proteins initiate viral DNA replication and maintain and partition viral genomes, in concert with the cellular replication machinery. Additionally, the E5, E6, and E7 proteins are required to evade host immune responses and to produce a cellular environment that supports viral DNA replication. An unfortunate consequence of the manipulation of cellular proliferation and differentiation is that cells become at high risk for carcinogenesis.

Identifiants

pubmed: 33672465
pii: v13020321
doi: 10.3390/v13020321
pmc: PMC7923415
pii:
doi:

Substances chimiques

DNA, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Intramural NIH HHS
ID : ZIA AI000713
Pays : United States

Références

mBio. 2017 Nov 21;8(6):
pubmed: 29162712
Cell. 2004 Apr 30;117(3):349-60
pubmed: 15109495
J Virol. 2011 Sep;85(17):8981-95
pubmed: 21734054
PLoS Pathog. 2013;9(7):e1003321
pubmed: 23853576
Int J Cancer. 2016 Nov 1;139(9):2001-11
pubmed: 27343048
Front Oncol. 2019 Aug 02;9:682
pubmed: 31428574
J Virol. 2006 Oct;80(19):9530-43
pubmed: 16973557
mBio. 2016 Nov 22;7(6):
pubmed: 27879331
PLoS Pathog. 2014 May 15;10(5):e1004117
pubmed: 24832099
J Virol. 2011 Sep;85(17):8996-9012
pubmed: 21734051
PLoS Pathog. 2016 Apr 11;12(4):e1005556
pubmed: 27064408
Virology. 2011 Jun 5;414(2):153-63
pubmed: 21492895
PLoS Pathog. 2014 May 29;10(5):e1004162
pubmed: 24874089
Rev Med Virol. 2015 Mar;25 Suppl 1:2-23
pubmed: 25752814
Virus Res. 2017 Mar 2;231:96-102
pubmed: 27825778
EMBO J. 1998 Dec 1;17(23):7044-55
pubmed: 9843509
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2290-5
pubmed: 9482878
Biol Chem. 2017 Jul 26;398(8):919-927
pubmed: 28315855
Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12398-402
pubmed: 7809048
Viruses. 2017 Aug 12;9(8):
pubmed: 28805675
J Virol. 1998 Mar;72(3):2079-88
pubmed: 9499063
Cell. 1993 Nov 5;75(3):495-505
pubmed: 8221889
PLoS Pathog. 2015 Apr 13;11(4):e1004763
pubmed: 25875106
Genes Dev. 2006 Sep 1;20(17):2383-96
pubmed: 16921027
Semin Immunopathol. 2020 Apr;42(2):159-171
pubmed: 31919577
Curr Opin Virol. 2014 Feb;4:24-31
pubmed: 24525291
PLoS Pathog. 2017 May 2;13(5):e1006200
pubmed: 28463988
Papillomavirus Res. 2019 Jun;7:82-87
pubmed: 30772498
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10516-21
pubmed: 22689991
Viruses. 2017 Aug 30;9(9):
pubmed: 28867768
J Virol. 2013 Jan;87(2):951-64
pubmed: 23135710
Cancer Res. 2000 Nov 1;60(21):5916-21
pubmed: 11085503
J Virol. 1998 Oct;72(10):8115-23
pubmed: 9733852
J Virol. 2014 Jan;88(2):937-47
pubmed: 24198405
Viruses. 2017 Sep 21;9(10):
pubmed: 28934151
Viruses. 2015 May 21;7(5):2485-506
pubmed: 26008697
Viruses. 2015 Jul 16;7(7):3863-90
pubmed: 26193301
J Virol. 1991 Feb;65(2):606-12
pubmed: 1846186
J Virol. 2007 Apr;81(8):4338-42
pubmed: 17287259
Curr Probl Dermatol. 2014;45:58-74
pubmed: 24643178
J Virol. 2004 Mar;78(5):2620-6
pubmed: 14963169
J Virol. 2015 May;89(9):4980-91
pubmed: 25694599
J Virol. 1989 May;63(5):2215-25
pubmed: 2539513
EMBO J. 1989 Dec 20;8(13):4099-105
pubmed: 2556261
PLoS Pathog. 2013;9(11):e1003777
pubmed: 24278023
Viruses. 2017 Aug 03;9(8):
pubmed: 28771189
Virus Res. 2017 Mar 2;231:76-82
pubmed: 27965149
Nature. 2017 Mar 16;543(7645):378-384
pubmed: 28112728
J Virol. 2009 Mar;83(6):2592-600
pubmed: 19129460
Int J Cancer. 2017 Aug 15;141(4):664-670
pubmed: 28369882
Nature. 1996 Mar 7;380(6569):79-82
pubmed: 8598912
J Virol. 2014 Mar;88(5):3027-30
pubmed: 24352452
Virology. 2013 Oct;445(1-2):57-79
pubmed: 23849793
Virology. 2000 Apr 25;270(1):124-34
pubmed: 10772985
J Virol. 2006 May;80(9):4431-9
pubmed: 16611903
PLoS Pathog. 2009 Oct;5(10):e1000605
pubmed: 19798429
Virology. 2004 Jun 20;324(1):17-27
pubmed: 15183049
Virus Evol. 2015 Jan;1(1):
pubmed: 27570633
Proc Natl Acad Sci U S A. 2019 Sep 24;116(39):19552-19562
pubmed: 31501315
PLoS One. 2015 Aug 19;10(8):e0135770
pubmed: 26288015
Pediatrics. 2016 Jul;138(1):
pubmed: 27296865
Nucleic Acids Res. 2017 Jan 4;45(D1):D499-D506
pubmed: 28053164
Curr Opin Virol. 2019 Dec;39:1-7
pubmed: 31302443
J Virol. 2014 Aug;88(15):8528-44
pubmed: 24850735
PLoS Pathog. 2017 Apr 6;13(4):e1006211
pubmed: 28384274
Virus Res. 2017 Mar 2;231:34-40
pubmed: 27826042
Mol Cell. 2005 Nov 11;20(3):377-89
pubmed: 16285920
J Virol. 2018 Apr 13;92(9):
pubmed: 29467315
PLoS Pathog. 2017 May 2;13(5):e1006308
pubmed: 28464022
Curr Opin Virol. 2012 Aug;2(4):459-66
pubmed: 22658985
Virology. 2013 Oct;445(1-2):35-56
pubmed: 24029589
Mod Pathol. 2015 Jul;28(7):994-1000
pubmed: 25975286
PLoS Pathog. 2019 Feb 25;15(2):e1007590
pubmed: 30802273
Aging (Albany NY). 2009 Mar 02;1(3):316-27
pubmed: 20157519
EMBO J. 1996 Jan 2;15(1):1-11
pubmed: 8598191
Nat Rev Cancer. 2010 Dec;10(12):878-89
pubmed: 21102637
Viruses. 2015 Jul 02;7(7):3530-51
pubmed: 26147797
J Virol. 2015 Apr;89(8):4668-75
pubmed: 25673709
Nat Commun. 2020 Feb 14;11(1):886
pubmed: 32060290
J Virol. 2018 Jan 17;92(3):
pubmed: 29142137
Microb Pathog. 2020 Feb;139:103923
pubmed: 31836496
PLoS Pathog. 2019 May 13;15(5):e1007755
pubmed: 31083694
Int J Cancer. 2006 Nov 1;119(9):2105-12
pubmed: 16823848
Viruses. 2015 May 21;7(5):2450-69
pubmed: 26008695
PLoS One. 2015 Mar 20;10(3):e0119566
pubmed: 25793388
EMBO J. 1991 Feb;10(2):449-57
pubmed: 1846806
J Virol. 2016 Aug 26;90(18):8032-5
pubmed: 27412595
J Virol. 2010 Nov;84(22):11747-60
pubmed: 20844047
Genes Chromosomes Cancer. 2017 Jan;56(1):59-74
pubmed: 27636103
J Virol. 2012 Mar;86(6):3276-83
pubmed: 22238312
J Biol Chem. 2011 Apr 29;286(17):15473-82
pubmed: 21321122
Annu Rev Virol. 2019 Sep 29;6(1):275-296
pubmed: 31283444
PLoS Pathog. 2015 Sep 25;11(9):e1005181
pubmed: 26405826
Open Virol J. 2012;6:190-7
pubmed: 23341854
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4549-53
pubmed: 1316611
Virology. 2007 Feb 5;358(1):10-7
pubmed: 17023018
J Virol. 2020 Jan 6;94(2):
pubmed: 31666385
PLoS Pathog. 2013 Oct;9(10):e1003717
pubmed: 24204267
Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1047-52
pubmed: 16415162
J Virol. 2015 Dec 23;90(5):2639-52
pubmed: 26699641
Nat Rev Dis Primers. 2016 Dec 01;2:16086
pubmed: 27905473
PLoS Pathog. 2016 Jun 16;12(6):e1005613
pubmed: 27310012
Oncotarget. 2017 Mar 21;8(12):19491-19506
pubmed: 28061478
Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2130-5
pubmed: 21245294
Virology. 2002 Feb 1;293(1):10-4
pubmed: 11853393
PLoS Pathog. 2018 Jan 11;14(1):e1006717
pubmed: 29324878

Auteurs

Ashley N Della Fera (AN)

Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 209892, USA.

Alix Warburton (A)

Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 209892, USA.

Tami L Coursey (TL)

Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 209892, USA.

Simran Khurana (S)

Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 209892, USA.

Alison A McBride (AA)

Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 209892, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH